These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2457309)

  • 1. Amsacrine is safe in patients with ventricular ectopy.
    Puccio CA; Feldman EJ; Arlin ZA
    Am J Hematol; 1988 Jul; 28(3):197-8. PubMed ID: 2457309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

  • 3. Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.
    Arlin ZA; Feldman EJ; Mittelman A; Ahmed T; Puccio C; Chun HG; Cook P; Baskind P; Marboe C; Mehta R
    Cancer; 1991 Sep; 68(6):1198-200. PubMed ID: 1873770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia.
    Arlin Z; Mehta R; Feldman E; Sullivan P; Pucillo A
    Cancer Chemother Pharmacol; 1987; 19(2):163-4. PubMed ID: 3568274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsacrine-associated cardiotoxicity: an analysis of 82 cases.
    Weiss RB; Grillo-López AJ; Marsoni S; Posada JG; Hess F; Ross BJ
    J Clin Oncol; 1986 Jun; 4(6):918-28. PubMed ID: 3519882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hypomagnesemia during Amsacrine treatment.
    Seymour JF
    Am J Hematol; 1993 Mar; 42(3):262-7. PubMed ID: 8438899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
    Krejci M; Doubek M; Dusek J; Brychtova Y; Racil Z; Navratil M; Tomiska M; Horky O; Pospisilova S; Mayer J
    Ann Hematol; 2013 Oct; 92(10):1397-403. PubMed ID: 23728608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
    Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
    Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
    Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 12. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.
    Larson RA; Day RS; Azarnia N; Bennett JM; Browman G; Goldberg J; Gottlieb A; Grunwald H; Miller K; Raza A
    Br J Haematol; 1992 Oct; 82(2):337-46. PubMed ID: 1419816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.
    Wilhelm C; Neubauer A; Burchert A
    Leuk Lymphoma; 2011 Oct; 52(10):2031-5. PubMed ID: 21702642
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy].
    Las Heras G; Ribera JM; Granada I; Millá F
    Sangre (Barc); 1991 Jun; 36(3):251-2. PubMed ID: 1948550
    [No Abstract]   [Full Text] [Related]  

  • 16. Triggered activity as the proposed mechanism of left atrial tachycardia induced by premature ventricular beats.
    Hluchý J; Milovský V; Uhliariková H
    Int J Cardiol; 1992 Mar; 34(3):342-5. PubMed ID: 1373411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.
    Klumper E; Ossenkoppele GJ; Pieters R; Huismans DR; Loonen AH; Rottier A; Westra G; Veerman AJ
    Br J Haematol; 1996 Jun; 93(4):903-10. PubMed ID: 8703824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amsacrine (m-AMSA), a new aminoacridine antitumor drug, on the rabbit heart.
    D'Alessandro N; Gebbia N; Crescimanno M; Flandina C; Leto G; Tumminello FM; Messina L
    Cancer Treat Rep; 1983 May; 67(5):467-74. PubMed ID: 6687838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase.
    Momparler RL; Doré BT; Labiberté J; Momparler LF
    Leukemia; 1993 May; 7 Suppl 1():17-20. PubMed ID: 7683351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral flecainide for the treatment of drug-resistant ventricular ectopy.
    Strasberg B; Stein S; Sclarovsky S
    Isr J Med Sci; 1990 May; 26(5):258-61. PubMed ID: 1696248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.